[BCG-polysaccharides-nucleic acid and its effect in the prophylactic treatment of the common cold].
The polysaccharides-nucleic acid fraction extracted from BCG was found out to be a good adjuvant. Through the activation and protective of the suppressed body immune system, particularly the macrophages and T cells, it gave good protection to the Sendai virus airway infection of C57BL mice, and clinical effect on the common cold susceptible.
Wang
H
H
D000818:Animals; D003139:Common Cold / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009163:Mycobacterium bovis; D009696:Nucleic Acids / Q000302:isolation & purification / Q000627:therapeutic use*; D010222:Parainfluenza Virus 1, Human; D018184:Paramyxoviridae Infections / Q000517:prevention & control*; D011135:Polysaccharides, Bacterial / Q000302:isolation & purification / Q000627:therapeutic use*; D013601:T-Lymphocytes / Q000276:immunology
D009696:Nucleic Acids; D011135:Polysaccharides, Bacterial